Gutbier et al. (76) confirmed that Ang-2 levels were significantly greater in ARDS patients than in healthy people in a prospective analysis of two different cohorts and that using Ang-2 as a particular biomarker could improve the CURB-65/CRB-65 grading system accuracy. The gene discussed is ANGPT2; the disease is acute respiratory distress syndrome.